Ipratroprium Bromide Spray, Metered
Product Images NDC 68682-398

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ipratroprium Bromide (NDC 68682-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton (Image 01)

Carton (Image 01)
This is a description of Ipratropium Bromide Nasal Solution 0.03%, manufactured by Bausch Health Companies Inc. in Italy. It is intended for intranasal use only in adults and children aged 6 years and older. The usual dosage is two sprays per nostril, two or three times daily. The solution is in a pH-adjusted isotonic aqueous solution containing additional ingredients like benzalkonium chloride and sodium chloride. A warning is included to prevent spraying near the eyes. The product should be stored at 20° to 25°C and kept out of reach of children. It is distributed by Oceanside Pharmaceuticals, which is a division of Bausch Health US, LLC.*
FDA Label Image

Chemical Formula (Image 02)

Chemical Formula (Image 02)
FDA Label Image

Figure 1 (Image 03)

Figure 1 (Image 03)
FDA Label Image

Figure 2 (Image 04)

Figure 2 (Image 04)
FDA Label Image

Figure 3 (Image 05)

Figure 3 (Image 05)
FDA Label Image

Figure 4 (Image 06)

Figure 4 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.